Şunu aradınız:: kontrastowe (Lehçe - İngilizce)

Środki kontrastowe
contrast media

produkty kontrastowe.
where appropriate, consideration should be made to providing concomitant treatment with a proton pump inhibitor. • patients with clinically significant infection requiring the use of antibiotics, antifungals, or antivirals, or who have completed prior anti-infectious therapy within 14 days of starting treatment should be treated with caution unless the use of antibiotics and antivirals were for prophylaxis purposes. • patients with a prior history of autoimmune disease (including systemic lupus, inflammatory bowel disease, psoriasis and rheumatoid arthritis) should be treated with caution. • monitoring of laboratory test results is recommended including standard haematological and blood chemistry tests. • patients receiving the following medicinal products should be treated with caution (see section 4.5) -beta-blockers or other anti-hypertensive agents. -h1 blocking agents and neuroleptics (anti-psychotics) with h1 receptor blocking properties. -tricyclic anti-depressants that may have h1 and h2 receptor blocking properties. -monoamine oxidase inhibitors and anti-malarial and anti-trypanosomal agents. -neuromuscular blocking agents, narcotic analgesics, and various contrast media.

rtg kontrastowe przełyku
barium swallow

pozostałe preparaty kontrastowe
other opacifying preparations

Środki kontrastowe zawierające jod
administration of iodinated contrast agent

odczynniki i środki kontrastowe
reagents and contrast media

mikropęcherzykowe środki kontrastowe w ultrasonografii
microbubbles

kontrastowe kolory ułatwiają poruszanie się.
colour contrast helps mobility

preparaty kontrastowe do badań rentgenowskich;
opacifying preparations for x-ray examinations;

badanie kontrastowe z użyciem gadolinu: brak danych.
1.4. gadolinium-enhancing lesions at baseline: no data.

preparaty kontrastowe do badań rentgenowskich; odczynniki diagnostyczne do badań pacjentów
opacifying preparations for x-ray examinations; diagnostic reagents designed to be administered to the patient

grupa farmakoterapeutyczna: środki kontrastowe do badań nmr, kod atc: v08ca06
pharmacotherapeutic group: mri contrast media, atc code: v08ca06

preparaty kontrastowe do badań rentgenowskich; odczynniki diagnostyczne przeznaczone do podawania pacjentom
opacifying preparations for x-ray examinations; diagnostic reagents designed to be administered to the patient

grupa farmakoterapeutyczna: Środki kontrastowe, paramagnetyczne środki kontrastowe, kod atc: v08 ca
pharmacotherapeutic group: contrast media, paramagnetic contrast media, atc code: v08ca.